$ZVRA
ZEVRA THERAPEUTICS, INC.

2018 Q1 Form 10-Q Financial Statement

#000143774918009627 Filed on May 11, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.130M $3.270M
YoY Change -4.28% -12.57%
% of Gross Profit
Research & Development $11.64M $4.114M
YoY Change 182.86% 27.21%
% of Gross Profit
Depreciation & Amortization $83.00K $80.00K
YoY Change 3.75% 207.69%
% of Gross Profit
Operating Expenses $14.77M $7.380M
YoY Change 100.12% 5.88%
Operating Profit -$14.77M -$7.380M
YoY Change 100.12% 5.88%
Interest Expense $1.442M $1.441M
YoY Change 0.07% 25.3%
% of Operating Profit
Other Income/Expense, Net -$11.46M -$8.946M
YoY Change 28.08% -321.0%
Pretax Income -$26.23M -$16.33M
YoY Change 60.65% 458.73%
Income Tax -$8.000K -$4.000K
% Of Pretax Income
Net Earnings -$26.22M -$16.32M
YoY Change 60.64% 456.31%
Net Earnings / Revenue
Basic Earnings Per Share -$1.11
Diluted Earnings Per Share -$28.50M -$1.11
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.60M $61.10M
YoY Change -43.37% -44.95%
Cash & Equivalents $8.750M $12.88M
Short-Term Investments $25.90M $48.20M
Other Short-Term Assets $2.900M $1.900M
YoY Change 52.63% 375.0%
Inventory
Prepaid Expenses
Receivables $1.511M
Other Receivables $0.00 $0.00
Total Short-Term Assets $39.08M $63.02M
YoY Change -37.99% -43.42%
LONG-TERM ASSETS
Property, Plant & Equipment $1.924M $2.201M
YoY Change -12.59% 450.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $10.20M
YoY Change -100.0%
Other Assets $1.646M $260.0K
YoY Change 533.08% 160.0%
Total Long-Term Assets $3.570M $12.62M
YoY Change -71.72% 2360.62%
TOTAL ASSETS
Total Short-Term Assets $39.08M $63.02M
Total Long-Term Assets $3.570M $12.62M
Total Assets $42.65M $75.64M
YoY Change -43.62% -32.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.20M $4.600M
YoY Change 121.74% 9.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.500M $200.0K
YoY Change 1650.0% -88.24%
Total Short-Term Liabilities $13.81M $4.808M
YoY Change 187.23% -17.74%
LONG-TERM LIABILITIES
Long-Term Debt $90.30M $91.60M
YoY Change -1.42% 1.66%
Other Long-Term Liabilities $769.0K $1.368M
YoY Change -43.79% 12336.36%
Total Long-Term Liabilities $769.0K $1.368M
YoY Change -43.79% 12336.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.81M $4.808M
Total Long-Term Liabilities $769.0K $1.368M
Total Liabilities $122.3M $109.6M
YoY Change 11.65% 1771.07%
SHAREHOLDERS EQUITY
Retained Earnings -$190.9M -$137.7M
YoY Change 38.71% 27.75%
Common Stock $111.3M $103.7M
YoY Change 7.26% 7.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$79.68M -$33.93M
YoY Change
Total Liabilities & Shareholders Equity $42.65M $75.64M
YoY Change -43.62% -32.43%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$26.22M -$16.32M
YoY Change 60.64% 456.31%
Depreciation, Depletion And Amortization $83.00K $80.00K
YoY Change 3.75% 207.69%
Cash From Operating Activities -$14.10M -$9.521M
YoY Change 48.08% 146.02%
INVESTING ACTIVITIES
Capital Expenditures $99.00K
YoY Change 50.0%
Acquisitions
YoY Change
Other Investing Activities $9.230M $5.800M
YoY Change 59.14% -139.54%
Cash From Investing Activities $9.229M $5.702M
YoY Change 61.86% -138.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.749M -63.00K
YoY Change -4463.49% -100.1%
NET CHANGE
Cash From Operating Activities -14.10M -9.521M
Cash From Investing Activities 9.229M 5.702M
Cash From Financing Activities 2.749M -63.00K
Net Change In Cash -2.121M -3.882M
YoY Change -45.36% -108.62%
FREE CASH FLOW
Cash From Operating Activities -$14.10M -$9.521M
Capital Expenditures $99.00K
Free Cash Flow -$14.10M -$9.620M
YoY Change 46.56% 144.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10177000
CY2018Q1 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
17450000
CY2017Q4 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
7709000
CY2018Q1 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-9741000
CY2017Q1 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-7216000
CY2018Q1 kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
3000
CY2017Q1 kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
2000
CY2018Q1 kmph Sale Of Securities Value Available To Issue
SaleOfSecuritiesValueAvailableToIssue
150000000
CY2018Q1 kmph Sale Of Stock Value Available To Issue
SaleOfStockValueAvailableToIssue
20000000
CY2018Q1 kmph Trade Receivables
TradeReceivables
1511000
CY2017Q1 kmph Trade Receivables
TradeReceivables
CY2018Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9741000
CY2018Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
187000
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
189000
CY2018Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2017Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
230000
CY2018Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
515000
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
562000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8750000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10871000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11971000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16762000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9850000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12880000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2121000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3882000
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
13200442
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12618711
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15104848
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14657430
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15104848
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14657430
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2018Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
89788000
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
89398000
CY2018Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3333000
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3333000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
83000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.77
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.11
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
17450000
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
11834000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7709000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4618000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3132000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3266000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26227000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16326000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1268000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2867000
CY2018Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-24000
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
68000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1650000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
206000
CY2018Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
115000
CY2017Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
101000
CY2018Q1 us-gaap Interest Expense
InterestExpense
1442000
CY2017Q1 us-gaap Interest Expense
InterestExpense
1441000
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
2618000
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
2617000
CY2018Q1 us-gaap Liabilities
Liabilities
122332000
CY2017Q4 us-gaap Liabilities
Liabilities
109972000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42649000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52456000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13810000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11509000
CY2018Q1 us-gaap Long Term Investments
LongTermInvestments
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
3250000
CY2018Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2017Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25873000
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
31358000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2749000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9229000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5702000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14099000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1307
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1281000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1089000
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
446111
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-79683000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-57516000
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1845000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1662000
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2798000
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9229000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
17471000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1924000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2004000
CY2018Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
49000
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
37000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11637000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4114000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190945000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164726000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2017Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP&nbsp;requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, including those related to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div>
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14791882
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14646982
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7875000
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1511000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2005000
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
111260000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
107209000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1281000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1089000
CY2018Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1031000
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1031000
CY2018Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2017Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12450670
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11703648
CY2018Q1 us-gaap Assets
Assets
42649000
CY2017Q4 us-gaap Assets
Assets
52456000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
39079000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
46996000
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7216000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9521000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-26219000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-16322000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11458000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8946000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
14769000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
7380000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-14769000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7380000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1646000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
206000
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
113000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
112000
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
769000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
794000
CY2018Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2017Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
26000
CY2018Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
CY2017Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
11670000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
99000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0

Files In Submission

Name View Source Status
0001437749-18-009627-index-headers.html Edgar Link pending
0001437749-18-009627-index.html Edgar Link pending
0001437749-18-009627.txt Edgar Link pending
0001437749-18-009627-xbrl.zip Edgar Link pending
ex_111146.htm Edgar Link pending
ex_111147.htm Edgar Link pending
ex_111148.htm Edgar Link pending
ex_111149.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kmph-20180331.xml Edgar Link completed
kmph-20180331.xsd Edgar Link pending
kmph-20180331_cal.xml Edgar Link unprocessable
kmph-20180331_def.xml Edgar Link unprocessable
kmph-20180331_lab.xml Edgar Link unprocessable
kmph-20180331_pre.xml Edgar Link unprocessable
kmph20180331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending